The Diagnostic-to-Discharge Bottleneck: An AI-Driven Model for Measuring Laboratory-Related Bed-Day Deficits and Reclaimable Hospital Resources
Arshiya
Department of Healthcare Management, School of Allied Health Sciences, Galgotias University, Greater Noida, 203201, India.
Ankita Singh
Department of Healthcare Management, School of Allied Health Sciences, Galgotias University, Greater Noida, 203201, India.
Aarohit Niranjan
Department of Healthcare Management, School of Allied Health Sciences, Galgotias University, Greater Noida, 203201, India.
Shivam Kumar
Department of Healthcare Management, School of Allied Health Sciences, Galgotias University, Greater Noida, 203201, India.
Ayogu Ebube Chidobendu
Department of Healthcare Management, School of Allied Health Sciences, Galgotias University, Greater Noida, 203201, India.
Ajit Pal Singh
*
Department of Medical Lab Technology, School of Allied Sciences, Galgotias University, Greater Noida, 203201, India.
*Author to whom correspondence should be addressed.
Abstract
Background: Hospital bed capacity depends on both the number of beds and how long patients occupy them. Waiting for diagnostic results can prolong hospital stays for patients who are otherwise clinically ready for discharge, although laboratory performance is judged almost entirely by turnaround time (TAT), which has no demonstrated link to bed occupancy. Raw TAT cannot be equated with bed-day loss because many pending results do not prevent discharge.
Objective: To propose and define an AI-enabled framework that identifies, quantifies, predicts and models laboratory-attributable discharge delay through three indices: Laboratory-Attributable Bed-Day Loss (LABL), the Diagnostic Discharge Delay Index (DDDI) and the Recoverable Bed Capacity Score (RBCS).
Methods: We propose a protocol for a retrospective, multisite cohort study using routinely collected admission, laboratory information system (LIS), discharge and bed-management data, to be reported in accordance with RECORD and TRIPOD+AI. Delay is attributed by event sequence: an interval is counted only when all non-laboratory discharge criteria are met (tR⊥), a clinically necessary result is still outstanding, with overlapping intervals from other pending tests counted only once (union of intervals). LABL is the overlap-adjusted attributable time in bed-days; DDDI is a prespecified 0–100 composite of delay frequency, magnitude and severity; RBCS is the share of LABL that evidence-based workflow changes could recover. Prediction models (regularised regression, tree ensembles and explainable boosting) will be developed at prespecified prediction times with temporal validation, calibration, decision-curve analysis and subgroup fairness assessment. Discrete-event simulation will convert counterfactual scenarios into recoverable bed-days, average daily recoverable beds and potential additional admissions. Validation will comprise blinded clinician review, timestamp audit, sensitivity analysis of attribution assumptions and, where possible, interrupted time-series analysis of real interventions.
Results: Not applicable, as this is a protocol and methodological framework. A worked numerical example (Section 5.6) and reporting templates (Table 3) are provided.
Conclusions: The framework reframes laboratory performance as a measurable determinant of hospital capacity and separates laboratory delay from clinical and organisational delay. The indices are proposed measures and require empirical validation before operational use.
Keywords: Laboratory turnaround time, discharge delay, bed-day loss, length of stay, discrete-event simulation, laboratory medicine